Introducing A Closer Look

In today’s hyper-connected world, you can find an almost infinite amount of information about Parkinson’s disease (PD) in every corner of the internet and on every social media outlet. It can be hard to know what to read, what to believe, and most importantly, what changes you should (or shouldn’t) implement in your life in response to the information that is out there.

Read More

The American Academy of Neurology (AAN) Annual Meeting – Parkinson’s Disease Updates

The American Academy of Neurology (AAN) Annual Meeting is taking place this week in Los Angeles, California. This is a meeting of neurologists and neuroscientists across all subspecialties of Neurology, including Movement disorders/Parkinson’s disease. At the meeting, research findings are presented, often for the first time. APDA is there and will be reporting exciting news […]

Read More

Traumatic Brain Injury and Parkinson’s

APDA’s Chief Scientific Officer Dr. Rebecca Gilbert weighs in on Traumatic Brian Injury, a small, but important contributor to the overall risk of Parkinson’s On April 18, 2018, a study was published in the journal Neurology and widely disseminated in the popular press, which demonstrated an increased risk of Parkinson’s disease (PD) after even a mild […]

Read More

APDA Updates Regarding PD Psychosis Treatment

On April 9, 2018, CNN published an article on the drug, Nuplazid, the only FDA-approved medication for the treatment of Parkinson’s disease psychosis. The American Parkinson Disease Association (APDA) recommends that patients discuss with their neurologists any concerns about the drug that the article may have raised. The FDA continues to monitor safety of this […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES REBECCA GILBERT, MD, PhD JOINS STAFF

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES REBECCA GILBERT, MD, PhD, JOINS STAFF AS VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER Role designed to shape research strategy to help those impacted by Parkinson’s disease live life to the fullest NEW YORK, NY – April 9, 2018 – The American Parkinson Disease Association (APDA) proudly welcomes Rebecca Gilbert, MD, PhD, in […]

Read More

American Parkinson Disease Association Launches New Public Service Awareness Campaign: LOOK CLOSER

Our Campaign Inspires People to Look Beyond Parkinson’s Disease and See People Living Life to the Fullest To kick-off Parkinson’s Disease Awareness Month, APDA is launching a brand new public service announcement (PSA) that encourages viewers to look closer at Parkinson’s disease (PD). Featured nationwide on television (in English and Spanish) and in a social […]

Read More

Brain Awareness Week

March 12-18 is Brain Awareness Week. The Brain Donor Project, is working to shed light on the critical need for brain donation to advance Parkinson’s disease (PD) research. According to the National Institutes of Health (NIH), there are vastly inadequate brain donations to meet the research demand of several disorders, in particular Parkinson’s. “Brain donation […]

Read More

Walking to End Parkinson’s Disease: American Parkinson Disease Association (APDA) Expands National Optimism Walk Series

More Cities. More Walkers. More Funds to Help People with Parkinson’s Live Life to the Fullest NEW YORK, NY, February 26, 2018 – The American Parkinson’s Disease Association (APDA) officially announces the schedule for the 2018 Optimism Walks — a nationwide movement to mobilize and inspire people to step up and help put an end to […]

Read More

EXCITING PARKINSON’S DISEASE TREATMENT NEWS

New York, NY, August 28, 2017 – The American Parkinson Disease Association is pleased to share with the Parkinson’s community the arrival of a new medication in the treatment arsenal to address Parkinson’s symptoms. Approved August 24 by the U.S. Food and Drug Administration is GOCOVRI™ (amantadine) developed by Adamas.  GOCOVRI is an extended release […]

Read More